Michal Mego - Concepedia

Author

Michal Mego

Also Known As

Jozef Mardiak, M Mego, M. MEGO, M. Mego, MICHAL MEGO, Mego M, Mego Michal, Mego, Michal, Michal Mego, Michal Mego (774807)

376

Publications

Citations

H-Index

Concepts

All Affiliations

Comenius University Bratislava Cancer Research Institute of the Slovak Academy of Sciences The University of Texas MD Anderson Cancer Center Slovak Academy of Sciences Biomedical Research Center of the Slovak Academy of Sciences

About

Michal Mego is an author at Comenius University Bratislava specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	2K
2	Cell Biology	13	16	1K
3	Health Sciences	4	4	161
4	Public Health	1	1	47
5	Environmental Health	1	1	47

Michal Mego

Publications

Citations

H-Index

Page 1

	Year	Citations
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment Mario Giuliano, Antonio Giordano, Summer Jackson, Breast Cancer Research	2011	224
Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer Antonio Giordano, Hui Gao, Simone Anfossi, Molecular Cancer Therapeutics Breast OncologyCancer Stem CellImmunologyImmunoeditingPathology	2012	223
Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study Michal Mego, Jozef Chovanec, Iveta Vochyanova-Andrezalova, Complementary Therapies in Medicine ProbioticDysbiosisMedicineGastroenterologyRandomized Double Blind	2015	222
Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy Michal Mego, Sendurai A. Mani, Bang‐Ning Lee, International Journal of Cancer Emt-inducing Transcription FactorsBreast OncologyNeoadjuvant TherapyMedicineEmt-inducing Tfs	2011	161
Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors Zuzana Čierna, Michal Mego, Věra Miškovská, Annals of Oncology Programmed-death-1 ReceptorGerm CellMalignant DiseaseEndocrine-related CancerMedicine	2015	161
Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer Ugo De Giorgi, Michal Mego, Emanuela Scarpi, Clinical Breast Cancer Metastatic Breast CancerRelationship Between LymphocytopeniaBreast OncologyMedicineCirculating Tumor Cells	2012	123
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination Mario Giuliano, Antonio Giordano, Summer Jackson, Breast Cancer Research	2014	122
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells Michal Mego, Ugo De Giorgi, Shahenaah Dawood, International Journal of Cancer Breast OncologyCancer ManagementPathologyTumor CellsTumor Biology	2010	116
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells Evan N. Cohen, Hui Gao, Simone Anfossi, PLoS ONE Breast OncologyImmunologyImmune RegulationBiological MicroenvironmentsImmunoediting	2015	115
Circulating tumor cells and bone metastases as detected by FDG–PET/CT in patients with metastatic breast cancer Ugo De Giorgi, V. Valero, Eric Rohren, Annals of Oncology Metastatic Breast CancerBreast OncologyOncologic ImagingCancer DetectionMedicine	2009	85

Page 1